» Articles » PMID: 35370722

Extracts of Maxim Ameliorate Acute Alcoholic Liver Disease Regulating Transcription Factors in Mice

Overview
Journal Front Pharmacol
Date 2022 Apr 4
PMID 35370722
Authors
Affiliations
Soon will be listed here.
Abstract

Alcoholic liver disease (ALD) caused by excessive drinking is a health and economic concern worldwide. Given the high morbidity, mortality, and the progressive nature of ALD, finding effective interventions is essential. Previous studies have confirmed that edible food plants and their bioactive compounds exert a protective effect against ALD. Maxim () is one of the important traditional Tibetan medicines in China with the effect of clearing away liver heat, used for the treatment of hepatitis. In this study, the chloroform extract (), ethyl acetate extract (), and n-butanol extract () were obtained by ethanol extraction combined with fractional extraction. Acute ALD was induced in mice given intragastric ethanol. Serum and liver biochemical markers were detected by ELISA. Liver histological observation, Oil Red O, and Masson's trichrome staining were performed. Liver injury cells were induced by ethanol. The cell vitality was detected by using MTT colorimetry. The expressions of Nrf2, NF-κB, STAT3, AP-1, CREB, HIF-1α, HO-1, NQO-1, GSTA1, IKB2, and Keap1 were detected by real-time polymerase chain reaction (PCR) to elucidate the mechanism of hepatoprotective effect, and the results were verified by using Western blot. The results of serum liver function indicators (ALT, AST, and ADH), serum hepatic lipid indicators (TC, TG, HDL-C, and LDL-C), and lipid peroxidation indicators (ADH, MDA, SOD, CAT, and GSH-Px) in liver tissue and liver histological observation showed that could improve liver function, alleviate fatty degeneration, edema, cell necrosis, and liver fibrosis caused by alcohol. also increased the vitality of EtOH-induced liver injury cells, upregulated the mRNA expression of Nrf2, HO-1, NQO-1, and GSTA1, while downregulated the expression of Keap-1, p65, and NF-κB. Western blot results were consistent with PCR. The results suggest that has a protective effect against ALD and , and its mechanism of action may be related to the activation of Nrf2/Keap-1 and inhibition of the P65/NF-κB signaling pathways.

Citing Articles

Potential Mechanisms and Effects of Dai Bai Jie Ethanol Extract in Preventing Acute Alcoholic Liver Injury.

Xia N, Xue H, Li Y, Liu J, Lou Y, Li S Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852118 PMC: 11763393. DOI: 10.3390/cimb47010003.


Pharmacophylogenetic relationships of genus and its related genera based on multifaceted analysis.

Liu H, Feng X, Zhao Y, Lv G, Zhang C, Aruhan Front Pharmacol. 2024; 15:1449426.

PMID: 39421668 PMC: 11484080. DOI: 10.3389/fphar.2024.1449426.


Elucidating the role of 4-hydroxy-2(3H)-benzoxazolone in chronic alcoholic liver disease via transcriptomics and metabolomics.

Lu J, Xing S, Wei X, Yang C, Zhao G, Ma X Front Pharmacol. 2024; 15:1447560.

PMID: 39323644 PMC: 11422225. DOI: 10.3389/fphar.2024.1447560.


Protective Effects of Murray against Acute Alcoholic Liver Disease in Mice via the Nrf2/HO-1/NF-κB Signaling Pathway.

Xia N, Ding Z, Dong M, Li S, Liu J, Xue H Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675458 PMC: 11054480. DOI: 10.3390/ph17040497.


Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities.

Yi M, Cruz Cisneros L, Cho E, Alexander M, Kimelman F, Swentek L Int J Mol Sci. 2024; 25(2).

PMID: 38255895 PMC: 10815857. DOI: 10.3390/ijms25020821.


References
1.
Liu Z, Dou W, Zheng Y, Wen Q, Qin M, Wang X . Curcumin upregulates Nrf2 nuclear translocation and protects rat hepatic stellate cells against oxidative stress. Mol Med Rep. 2015; 13(2):1717-24. DOI: 10.3892/mmr.2015.4690. View

2.
Kim H, Chang Y, Park J, Ahn H, Cho H, Han S . Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism. J Gastroenterol Hepatol. 2015; 31(2):427-33. DOI: 10.1111/jgh.13084. View

3.
Singh S, Osna N, Kharbanda K . Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol. 2017; 23(36):6549-6570. PMC: 5643281. DOI: 10.3748/wjg.v23.i36.6549. View

4.
Yuan D, Wang Y, Huang P, Cui X, Zhou X, Liang Y . [Summary and prospect of medicinal plant active substances in regulation of p65 nuclear translocation]. Zhongguo Zhong Yao Za Zhi. 2017; 42(17):3286-3293. DOI: 10.19540/j.cnki.cjcmm.20170731.003. View

5.
Singal A, Bataller R, Ahn J, Kamath P, Shah V . ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018; 113(2):175-194. PMC: 6524956. DOI: 10.1038/ajg.2017.469. View